NASDAQ: SERASera Prognostics Inc Stock Ownership - Who owns Sera Prognostics?
Insider buying vs selling
Have Sera Prognostics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Benjamin Jackson | General Counsel | 2026-06-11 | 2,179 | $2.01 | $4.38kSell |
| Tiffany Eul Davis Inglis | Chief Medical Officer | 2026-06-11 | 362 | $2.01 | $727.62Sell |
| Zhenya Lindgardt | Chief Executive Officer | 2026-06-11 | 6,990 | $2.01 | $14.05kSell |
| Austin Aerts | Chief Financial Officer | 2026-06-11 | 2,037 | $2.01 | $4.09kSell |
| Dyaarl Lee Anderson Jr. | Chief Commercial Officer | 2026-06-11 | 4,739 | $2.01 | $9.53kSell |
| Austin Aerts | Chief Financial Officer | 2026-06-09 | 5,440 | $2.08 | $11.32kSell |
| Zhenya Lindgardt | Chief Executive Officer | 2026-06-09 | 20,755 | $2.08 | $43.17kSell |
| Sandra Aj Lawrence | Director | 2026-06-08 | 1,560 | $2.15 | $3.35kSell |
| Benjamin Jackson | General Counsel | 2026-05-29 | 5,000 | $1.84 | $9.20kBuy |
| Dyaarl Lee Anderson Jr. | Chief Commercial Officer | 2026-05-29 | 3,168 | $1.84 | $5.83kBuy |
SERA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when SERA insiders and whales buy or sell their stock.
SERA Shareholders
What type of owners hold Sera Prognostics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Baker Bros Advisors LP | 12.84% | 5,065,736 | $10.84M | Insider |
| Gregory C. Critchfield | 3.75% | 1,477,718 | $3.16M | Insider |
| Zhenya Lindgardt | 2.19% | 865,009 | $1.85M | Insider |
| Joshua Phillips | 1.62% | 638,707 | $1.37M | Insider |
| Austin Aerts | 0.76% | 301,190 | $644.55k | Insider |
| Blue Ox Healthcare Partners LLC | 0.65% | 256,665 | $549.26k | Insider |
| Douglas Fisher | 0.56% | 220,562 | $472.00k | Insider |
| Paul Kearney | 0.42% | 163,961 | $350.88k | Insider |
| Benjamin Jackson | 0.41% | 161,756 | $346.16k | Insider |
| John J. Boniface | 0.37% | 145,842 | $312.10k | Insider |
SERA vs Diagnostic & Research Stocks
Sera Prognostics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.